Pharmaceutical Ethics and Pandemic Responses

This chapter explores the controversial practices of pharmaceutical companies, particularly the case of Vioxx, and highlights systemic issues regarding government mandates and accountability during the COVID-19 pandemic. It examines the impact of medical interventions like ventilators on patients, discusses the long-term societal consequences of lockdowns and government responses, and critiques the effectiveness of safety measures. Reflecting on these events, the chapter calls for a reevaluation of pandemic strategies to prioritize public health without compromising economic and social stability.